LifeStance Health (LFST) Shares Outstanding (Weighted Average) (2020 - 2026)

LifeStance Health (LFST) has 7 years of Shares Outstanding (Weighted Average) data on file, last reported at $387.3 million in Q1 2026.

• Quarterly Shares Outstanding (Weighted Average) rose 1.04% year-over-year to $387.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $387.3 million (up 1.04% YoY) and the FY2025 annual result came in at $386.0 million, up 1.81% from the prior year.
• Shares Outstanding (Weighted Average) was little changed at $387.3 million in Q1 2026 per LFST's latest filing, from $386.0 million in the prior quarter.
• Across five years, Shares Outstanding (Weighted Average) topped out at $387.3 million in Q1 2026 and bottomed at $350849.0 in Q1 2022.
• The 5-year median for Shares Outstanding (Weighted Average) is $376.3 million (2024), against an average of $309.4 million.
• The widest annual swing landed in 2022, when Shares Outstanding (Weighted Average) soared 108374.21%; it then grew 1.04% in 2026.
• Tracing LFST's Shares Outstanding (Weighted Average) over 5 years: stood at $355.3 million in 2022, then advanced by 3.43% to $367.5 million in 2023, then rose by 3.18% to $379.1 million in 2024, then climbed by 1.81% to $386.0 million in 2025, then rose by 0.32% to $387.3 million in 2026.
• Per Business Quant, the three latest LFST Shares Outstanding (Weighted Average) figures stand at $387.3 million (Q1 2026), $386.0 million (Q4 2025), and $385.7 million (Q3 2025).

Peer Comparison